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ABSTRACT
Diabetes is associated with dysfunction of the neurovascular unit,
although the mechanisms of this are incompletely understood and
currently no treatment exists to prevent these negative effects.
We previously found that the nitric oxide (NO) donor sodium
nitroprusside (SNP) prevents the detrimental effect of glucose on
neurovascular coupling in zebrafish. We therefore sought to establish
the wider effects of glucose exposure on both the neurovascular unit
and on behaviour in zebrafish, and the ability of SNP to prevent these.
We incubated 4-days post-fertilisation (dpf) zebrafish embryos in
20 mM glucose or mannitol for 5 days until 9 dpf, with or without
0.1 mM SNP co-treatment for 24 h (8-9 dpf), and quantified vascular
NO reactivity, vascular mural cell number, expression of a klf2a
reporter, glial fibrillary acidic protein (GFAP) and transient receptor
potential cation channel subfamily V member 4 (TRPV4), as well as
spontaneous neuronal activation at 9 dpf, all in the optic tectum.
We also assessed the effect on light/dark preference and locomotory
characteristics during free-swimming studies. We find that
glucose exposure significantly reduced NO reactivity, klf2a reporter
expression, vascular mural cell number and TRPV4 expression,
while significantly increasing spontaneous neuronal activation and
GFAP expression (all in the optic tectum). Furthermore, when we
examined larval behaviour, we found that glucose exposure
significantly altered light/dark preference and high and low speed
locomotion while in light. Co-treatment with SNP reversed all these
molecular and behavioural effects of glucose exposure. Our findings
comprehensively describe the negative effects of glucose exposure
on the vascular anatomy, molecular phenotype and function of the
optic tectum, and on whole-organism behaviour. We also show that
SNP or other NO donors may represent a therapeutic strategy to
ameliorate the complications of diabetes on the neurovascular unit.
This article has an associated First Person interview with the first
author of the paper.
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INTRODUCTION
The prevalence of diabetes has quadrupled in the previous two
decades, incurring an enormous burden of morbidity and healthcare
expenditure worldwide (Zhang et al., 2010; Scully, 2012). Diabetes is
a risk factor for bothmacrovascular (such as myocardial infarction and
stroke) and microvascular (causing renal impairment and retinopathy)
disease (Chase et al., 1989; Jørgensen et al., 1994; Miettinen et al.,
1998; Stratton et al., 2000). Diabetes is also associated with
neurological disorders, including cognitive impairment (dementia)
(Stewart and Liolitsa, 1999; Areosa and Grimley, 2002; MacKnight
et al., 2002; Ciudin et al., 2017; Simó et al., 2017; Groeneveld et al.,
2018). The mechanisms underlying this association are incompletely
understood, and no specific therapies have been identified to prevent
or reverse the effects of diabetes on neurological function.
Both diabetes and neurological diseases are associated with
dysfunction of the neurovascular unit (NVU) (Zlokovic, 2010;
Mogi and Horiuchi, 2011; Gardner and Davila, 2017). The NVU
comprises neurons, astrocytes, myocytes, pericytes, endothelial cells
(ECs) and extracellular matrix. Interactions between these ensures that
neuronal energy demands are met through increased local blood flow
via neurovascular coupling (NVC) (Roy and Sherrington, 1890;
Attwell et al., 2010). Recent evidence suggests that ECs are crucial to
NVU function (Toth et al., 2015; Guerra et al., 2018) as they release
vasoactive substances such as nitric oxide (NO) (Ignarro et al., 1987;
Palmer et al., 1987). NO production is regulated by various endothelial
genes, including the Kruppel-like family of transcription factors
(KLFs) (Gracia-Sancho et al., 2011), particularly KLF2, which is
regulated by changes in flow and inflammation (Dekker et al., 2002;
SenBanerjee et al., 2004). ECs share a common basement membrane
with pericytes that aid EC development (Gerhardt and Betsholtz,
2003). Pericyte coverage, essential to both blood-brain barrier (BBB)
integrity and NVC, is affected in various neuropathologies (Tilton
et al., 1985; Frank et al., 1990; Peppiatt et al., 2006; Pfister et al., 2008;
Vates et al., 2010; Sagare et al., 2013; Hall et al., 2014). Astrocytes are
the predominant glial cell in the brain and perform several functions,
including release of vasoactive factors (Zonta et al., 2003; Takano
et al., 2006). Astrocytes also express glutamine synthetase (GS), an
enzyme involved in the recycling of glutamate released by active
neurons (Bergles et al., 1999; Bringmann et al., 2013). Mammalian
studies show that astrocytes sense changes in vascular tone through
activation of the mechanosensor TRPV4 (transient receptor potential
cation channel subfamily V member 4) (Filosa et al., 2013), which is
also expressed in ECs. Together, all these cell types maintain the
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The zebrafish is increasingly used as a model of human
disease (Dooley and Zon, 2000; Lieschke and Currie, 2007). This
has a number of advantages over existing mammalian models,
particularly ease of in vivo cellular imaging and the ability to test
the effect of drugs by immersion. Although most zebrafish studies
attempting to model human disease have examined the anatomical
or molecular effects of genetic or other manipulation (Patton and
Zon, 2001; Lieschke and Currie, 2007), a range of behavioural
assays have been applied to study more complex ‘whole organism’
phenotypes, such as memory or aggression (Blaser and Gerlai,
2006; Oliveira et al., 2011). The zebrafish has previously been
used as a model of diabetes, either by exposure to medium
containing glucose (Capiotti et al., 2014), genetic manipulation
(Kimmel et al., 2015) or ablation of the β-cells of the pancreas
(Pisharath et al., 2007).
We recently established a novel zebrafish larval model of NVC in
which incubation of larvae in 20 mM glucose impaired NVC. We
found that the NO donor sodium nitroprusside (SNP) rescued this
effect (Chhabria et al., 2018), although the mechanism for this is
unclear. We therefore wish to better understand the mechanism and
consequences of NVUdysfunction induced by glucose. In the present
study, we have now examined the effect of glucose exposure on: NO
production in the NVU, klf2a expression, mural cell number, glial
fibrillary acidic protein (GFAP) expression, TRPV4 expression,
spontaneous neuronal activation, light/dark preference and larval
locomotory behaviour (exploratory and thigmotactic). We find that
glucose exposure affects all these aspects of NVU function and
behaviour, and that co-treatment with SNP completely prevents all
the detrimental effects of glucose exposure. Our findings provide
insight into the effect of hyperglycemia on NVU function and further
Fig. 1. Effect of mannitol/glucose treatment with/without
sodium nitroprusside (SNP) on nitric oxide (NO)
reactivity, quantified by intensity of DAF-FM staining.
(A) Representative micrographs of tectal vessels showing
separate and merged channels (green: DAF-FM staining;
red: kdrl:HRAS-mCherry) for 20 mM mannitol- or glucose-
exposed larvae co-treated with or without SNP. Scale bars:
20 µm. (B) Quantification of DAF-FM intensity in the tectal
vessels (n=25, 24, 27 and 24 larvae for mannitol,
mannitol+SNP, glucose and glucose+SNP, respectively).
Data are mean±s.e.m. *P<0.05.
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support for the possibility that NO donors represent plausible drug
candidates to ameliorate the detrimental effects of hyperglycemia.
RESULTS
SNP co-treatment prevents the reduced vascular NO
reactivity caused by glucose exposure
Studies with diabetic patients have shown reduced bioavailability
of NO in ECs (Williams et al., 1996; Pieper, 1998). We therefore first
examined whether glucose exposure reduces NO availability in the
cerebral vessels.We used diaminofluorescein-FM (DAF-FM) staining
to visualise NO reactivity in 9 days post-fertilisation (dpf) zebrafish
embryos exposed to 20 mM glucose or mannitol (as osmotic control)
with or without co-treatment with 0.1 mM SNP. Representative
micrographs of the vessels in the left optic tectumare shown inFig. 1A.
We observed variable levels of NO reactivity that colocalised with the
kdrl:HRAS-mCherry endothelial reporter in animals treated with
mannitol. Co-treatment with mannitol and the NO donor, SNP, did not
alter the intensity of vascular NO reactivity compared to treatment with
mannitol alone (Fig. 1). Exposure to glucose significantly reduced
vascularNO reactivity in the tectal vessels (Fig. 1), in keepingwith data
from other models (Pieper, 1998; Du et al., 2001). Co-treatment with
SNP prevented this reduction in vascular NO reactivity (Fig. 1).
SNP co-treatment prevents the reduced endothelial klf2a
expression caused by glucose exposure
The shear-stress-responsive transcription factor klf2a is protective
against vascular disease (Dekker et al., 2002, 2005; Chiu et al., 2009).
To determine whether glucose exposure affects endothelial shear-
stress sensing and klf2a expression, we quantified the intensity of a
Tg(klf2a:GFP) reporter in the cerebral vessels of zebrafish with
glucose or mannitol with or without SNP co-treatment.
Representative micrographs are shown in Fig. 2A. Glucose
exposure significantly reduced intensity of the klf2a:GFP reporter
compared to mannitol alone (Fig. 2B). Although SNP co-treatment
with mannitol had no effect compared with mannitol alone (Fig. 2B),
SNP co-treatment prevented the glucose-induced reduction in klf2a
reporter expression.
SNP co-treatment prevents the reduced number of vascular
mural cells on the tectal vessels caused by glucose
exposure
NO is required for mural cell function and can evoke
hyperpolarization in mural cells (including pericyte and smooth
muscle cell), causing vasodilation (Sakagami et al., 2001; Lee et al.,
2005). Mural cell loss is a feature of diabetes (Pfister et al., 2008),
but no therapy has been shown to reverse this. We therefore
examined the effect of glucose on vascular mural cells. We used an
sm22ab:nls-mCherry reporter to quantify the number of vascular
mural cells present in the optic tectum. Representative micrographs
are shown in Fig. 2C. Glucose exposure induced a significant
reduction in the number of vascular mural cells compared with
either mannitol or mannitol plus SNP (Fig. 2D). Co-treatment with
SNP prevented the reduction of vascular mural cells induced by
glucose exposure.
Fig. 2. Effect of mannitol/glucose
treatment with/without sodium
nitroprusside (SNP) on klf2a:GFP
expression and number of mural cells on
the tectal vessels. (A) Representative
micrographs of tectal vessels in Tg(klf2a:
GFP) exposed to 20 mM mannitol or glucose
co-treated with or without SNP. Scale bars:
20 µm. (B) Quantification of klf2a:GFP
intensity in the tectal vessels (n=26 larvae/
group). (C) Representative micrographs of
tectal vessels showing separate and merged
channels (green: fli1:GFF:UAS:GCaMP6;
red: sm222ab:nls-mCherry sh480) for 20 mM
mannitol- or glucose-exposed larvae co-
treated with or without SNP. Scale bars:
20 µm. Arrows indicate mural cell nuclei.
(D) Quantification of the number of sm22ab:
nls-mCherrysh480 nuclei on the tectal vessels
for 20 mM mannitol- or glucose-exposed
larvae co-treated with or without SNP (n=28
larvae/group). Data are mean±s.e.m.
*P<0.05, **P<0.01.
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SNP co-treatment prevents the increased GFAP expression
in the optic tectum caused by glucose exposure
Glial cells play major roles in the maintenance of the BBB and NVU
function (Janzer and Raff, 1987; Prat et al., 2001). Experimental
studies have shown overexpression of GFAP (termed astrogliosis) in
response to both hyperglycemia and type 1 diabetes (Coleman et al.,
2004). We thus examined the effect of glucose or mannitol with or
without SNP on GFAP expression. Representative micrographs
of whole-mount 9 dpf zebrafish are shown in Fig. 3A. Glucose
exposure increased GFAP expression compared to mannitol
treatment (Fig. 3B), in keeping with astrogliosis in other diabetic
models (Coleman et al., 2004). This was prevented by co-treatment
with SNP (Fig. 3B).
SNPco-treatmentprevents the reducedexpressionofTRPV4
in the optic tectum caused by glucose exposure
Since hyperglycemia downregulates TRPV4 in the ECs of the retinal
microvasculature (Monaghan et al., 2015), we investigated TRPV4
expression by immunohistochemistry (IHC) in 9 dpf zebrafish larvae
exposed to glucose or mannitol with or without SNP treatment.
We performed IHC for TRPV4 to first compare expression patterns
in the optic tectum. Representative micrographs are shown in
Fig. 4A. Glucose exposure decreased tectal TRPV4 expression
(which includes radial glial, endothelial or neuronal expression of
TRPV4) compared to mannitol exposure. Co-treatment with SNP
prevented the effect of glucose on TRPV4 expression (Fig. 4B).
SNP co-treatment prevents the reduced expression
of glutamine synthetase in the optic tectum caused
by glucose exposure
GS, a glial-specific enzyme involved in recycling of extracellular/
extrasynaptic glutamate to glutamine, is reduced in neurological
disorders and diabetes (Lieth et al., 2000; Burbaeva et al., 2003).
We therefore examined expression of GS in the optic tectum.
Glucose exposure induced a significant reduction in GS expression,
which was prevented by SNP co-treatment (Fig. 4C,D).
SNP co-treatment prevents the increased frequency
of spontaneous neuronal calcium transients caused
by glucose exposure
The previous results showed that glucose exposure affects both the
anatomy of the NVU (vascular mural cell loss) and induces
dysregulation of gene expression, including a reduction of GS,
which might be expected to cause neuronal hyperexcitability.
We therefore quantified neuronal activity in our model.
Representative time series of spontaneous neuronal activation
(quantified as ΔF/Fo) in larvae exposed to mannitol or glucose with
or without SNP are shown in Fig. 5A. Glucose exposure increased
neuronal activation compared to mannitol exposure (Fig. 5B). Co-
treatment with SNP prevented this glucose-induced increase in
neuronal activation (Fig. 5B), suggesting that diabetes-induced
neuronal hyperexcitability may be mediated via reduced NO
bioavailability.
Fig. 3. Effect of mannitol/glucose treatment
with/without sodium nitroprusside (SNP) on
glial fibrillary acidic protein (GFAP)
expression. (A) Representative micrographs
showing the effect of mannitol/glucose
exposure with or without SNP treatment on
GFAP expression (red channel represents
GFAP; blue channel represents DAPI). Scale
bars: 20 µm. (B) Quantification of GFAP
expression in the optic tectum (n=16, 12, 18
and 20 larvae for mannitol, mannitol+SNP,
glucose and glucose+SNP, respectively). Data
are mean±s.e.m. *P<0.05, ***P<0.001.
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SNP co-treatment prevents the altered light/dark preference
and locomotion caused by glucose exposure
Although the previous data clearly demonstrate molecular and
functional defects of the NVU induced by glucose, if such
disturbances are clinically relevant, they would be expected to
manifest in overt behavioural or neurological consequences. We
therefore assessed the effect of glucose exposure on free-swimming
behaviour in zebrafish larvae to attempt to identify behavioural
consequences of glucose exposure. We first examined the effect of
glucose exposure on light/dark preference. Figure 6A shows the
trajectories of representative zebrafish larvae for a period of 1 h in
each treatment group. Red and green paths indicate high and low
speed locomotion, respectively.We tested light/dark preference using
the percentage of time spent in the light or dark side of the well.
Mannitol-exposed larvae at 9 dpf showed a preference for light,
spending∼80% of time in the light. Thiswas significantly reduced by
glucose exposure (Fig. 6B). However, co-treatment with SNP
prevented the effect of glucose on light/dark preference (Fig. 6B).
To further characterise larval behaviour, we quantified the time
spent in high speed (>6.4 mm/s), low speed (3.3-6.3 mm/s) and
inactive (<3.3 mm/s) locomotion in the light or dark side of the wells
(Fig. 6C,D). Glucose exposure significantly increased the time larvae
spent in both low and high speed locomotion while in the light, and
SNP prevented this effect (Fig. 6C). In contrast, glucose did not
induce any significant difference in the amount of time spent in either
high or low speed locomotion while in the dark side of the well
(Fig. 6D). We quantified the number of transitions between light and
dark areas of the well and found that glucose exposure induced a
significant increase in the number of transitions, and that this increase
was prevented by co-treatment with SNP (Fig. 6E).
We next investigated three further features of larval zebrafish
locomotion; path eccentricity, mean point distance to ellipsoid
(MPDE) and mean point distance to centre (MPDC) (Fig. S1) in the
light and dark sides of the wells. Glucose induced significant
increases in both exploratory behaviour (as measured by path
eccentricities and MPDE) and thigmotaxis (MPDC) in the light side
of the well; these increases were prevented by SNP (Fig. 7A-C).
When we quantified these behaviours in the dark side of thewell, we
saw a similar significant increase in path eccentricity andMPDE but
not in MPDC (Fig. 7D-F). When we performed the same analysis in
blocks of 15 min, we found that these effects were apparent at
different times during the hour-long observation period. Notably,
the significantly higher proportion of time spent in both high and
low speed locomotion in light conditions for zebrafish exposed to
Fig. 4. Effect of mannitol/glucose
treatment with/without sodium
nitroprusside (SNP) on TRPV4 and
glutamine synthetase (GS).
(A) Representative micrographs of optic
tectum showing the effect of mannitol/
glucose treatment with/without SNP
treatment on the expression of TRPV4.
Scale bars: 20 µm. (B) Quantification of the
TRPV4 intensity in the optic tectum in a
fixed volume of the tissue (n=21, 20, 24 and
26 larvae for mannitol, mannitol+SNP,
glucose and glucose+SNP, respectively).
(C) Representative micrographs of optic
tectum showing the effect of mannitol/
glucose treatment with/without SNP
treatment on the expression of GS. Scale
bars: 20 µm. (D) Quantification of the GS
intensity in the optic tectum in a fixed
volume of tissue (n=21, 20, 24 and 26
larvae for mannitol, mannitol+SNP, glucose
and glucose+SNP, respectively). Data are
mean±s.e.m. *P<0.05, **P<0.01,
****P<0.0001.
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glucose was only observed early in the period of observation
(Fig. S1), with no differences at 45 or 60 min. In contrast, the
increases in light/dark transitions, path eccentricity, MPDE and
MPDC in glucose-exposed zebrafish were spread more evenly
across the entire observation period (Figs S1, S2). Again, SNP
prevented the effect of glucose on these aspects of behaviour.
DISCUSSION
Here, we describe a comprehensive molecular, anatomical,
functional and behavioural study of the effect of glucose exposure
on the NVU in zebrafish. The zebrafish model has a range of
advantages, coupling simplicity, speed and cost-effectiveness with
sophisticated in vivo imaging in a whole-organism setting. We show
that a relatively short (5 days) exposure to 20 mM glucose [a
concentration seen in the blood of humans with poorly controlled
diabetes (Amiel et al., 1988; Boyle et al., 1988)] affects every
constituent cell type of the NVU that we examined.
Glucose exposure impaired both vascular NO production and
vascular mural cell number, which builds on our previous work
showing that tectal endothelial patterning is impaired by glucose
exposure (Chhabria et al., 2018). These effects were also associated
with reduced endothelial klf2a expression, which is known to
promote vascular inflammatory gene expression, thrombosis and
atherosclerosis (SenBanerjee et al., 2004; Lin et al., 2005).
Developmental studies in klf2a−/− mice have shown reduced
vascular mural cell recruitment, suggesting the role of klf2a in
maintaining endothelial-mural cell interactions (Wu et al., 2008;
Fukuhara et al., 2009; Gaengel et al., 2009). Abnormal mural cell
recruitment ormigration is associated with variousmicroangiopathies
and is commonlyobserved in diabetes (Hammes et al., 2002; Gaengel
et al., 2009).
In addition to the negative effects of glucose on the vascular
component of the NVU, we found that glucose exposure induced
upregulation of GFAP, indicating astrogliosis, with concomitant
reductions in GS and TRPV4. In both rodents and zebrafish, TRPV4
channels are expressed on astrocytes, neurons and ECs (Vriens et al.,
2005; Benfenati et al., 2007; Grant et al., 2007; Mangos et al., 2007;
Marrelli et al., 2007; Amato et al., 2012). Interestingly, studies have
shown that TRPV4 in ECs can regulate endothelial NO synthase
(eNOS) (Sukumaran et al., 2013) and the presence of a feedback loop
from eNOS to TRPV4 to modulate TRPV4-based Ca2+ signalling
(Yin et al., 2008). Rodent models have shown that TRPV4 on cortical
astrocyte endfeet can evoke changes in intracellular astrocyte Ca2+
concentration, thereby modulating vascular tone and contributing to
NVC (Dunn et al., 2013; Filosa et al., 2013). Rodent experiments
support our observations by showing TRPV4 downregulation in
streptozotocin-induced diabetes (Monaghan et al., 2015).
Retinal studies with streptozotocin-induced hyperglycemia in
rodents have suggested that hyperplasia of Müller cells (retinal
analogue of astrocytes) could lead to an increase in GFAP (Newman
and Reichenbach, 1996; Rungger-Brandle et al., 2000). Astrocytic
glutamate clearance is also impaired under high glucose conditions
(Coleman et al., 2004), making neurons susceptible to
depolarization, a possible cause of neurotoxicity. This could result
Fig. 5. Effect of mannitol/glucose treatment
with/without sodium nitroprusside (SNP) on
frequency of spontaneous neuronal calcium
transients. (A) Time series of neuronal
activation (ΔF/Fo) in zebrafish (5 larvae/group)
exposed to mannitol, mannitol+SNP, glucose or
glucose+SNP. Arrowheads indicate the
detected peaks. (B) Quantification of frequency
of neuronal calcium transients for each of the
groups (n=28 larvae/group). Data are mean±
s.d. in A (mean shown in green, s.d. shown in
grey) and mean±s.e.m. in B. *P<0.05.
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in accumulation of glutamate in the extrasynaptic space, leading to
recurrent neuronal depolarization. This is concordant with our
observation of an increased number of spontaneous Ca2+ peaks in
the glucose-treated larvae. Neuronal hyperexcitability and increased
firing is known to be associated with seizures, commonly observed
in diabetic patients (Martinez and Megias, 2009; Baviera et al.,
2017). The various cellular markers shown here to be affected by
glucose exposure could explain a predisposition of diabetics to
seizures. Increased neuronal firing could also lead to abnormal and
non-precise pre- and post-synaptic neuronal firing, causing defects
in the synaptic plasticity mechanisms necessary for cognition and
memory. Further exploration of this could help define the
relationship between diabetes and cognitive defects.
The anatomical and molecular effects of glucose exposure on the
NVU were associated with altered embryonic behaviour, with a
reduction in preference for light, which is a measure of unconditioned
anxiety and related disorders in rodents and zebrafish (Kulesskaya and
Voikar, 2014; Kysil et al., 2017). Unconditioned anxiety is influenced
by environmental, emotional and cognitive factors (Arrant et al.,
2013). It is based on an approach/avoidance conflict between the drive
to explore a novel area and an aversion to brightly lit/completely dark
open spaces in adult/larval zebrafish, respectively (Bourin and
Hascoet, 2003; Arrant et al., 2013). The approach/avoidance conflict
is well studied in mammals and is known to have various neural
substrates in the brain, such as in the limbic system, anterior cingulate
cortex, ventral striatum and prefrontal cortex (Aupperle et al., 2015).
Although zebrafish do not possess a cortex, their ventral and dorsal
telencephalic area (Vd and Dm, respectively) are homologous to the
mammalian amygdala and striatum (Maximino et al., 2013). Thus,
impaired light/dark preference as described in the present study could
imply an abnormal circuitry in the zebrafish Vd/Dm. Anatomical
studies with zebrafish have shown that the Vd/Dm system projects to
the optic tectum and hence any defects could also affect the optic
tectum (Scott and Baier, 2009; Nevin et al., 2010).
Various studies have described larval zebrafish behavioural
differences with anxiolytic or anxiogenic treatments (Egan et al.,
2009; Richendrfer et al., 2012). However, this is the first study
characterising the effect of hyperglycemia on geometrical and
positional characteristics of zebrafish locomotion. Glucose
exposure resulted in an increase in both exploration (as measured
by the geometric features, eccentricity and MPDE) and thigmotaxis
(as measured by an increase in the positional feature, MPDC).
Various zebrafish studies have shown increased exploration and
thigmotaxis with anxiogenic drug treatments (Egan et al., 2009;
Blaser et al., 2010). This further points to the association of glucose
exposure and diabetes to anxiety-related brain activation, which
warrants further investigation. The use of behavioural assays, such
as the novel-tank diving test (Levin et al., 2007), to assess anxiety-
Fig. 6. Effect of mannitol/glucose treatment with/without
sodium nitroprusside (SNP) on larval zebrafish
behaviour. (A) Representative trajectories of 9 dpf zebrafish
moving in half-darkened wells (of a 12-well plate) as tracked
by Viewpoint software for mannitol or glucose with or without
SNP treatment. Red trajectories represent high speed
(>6.4 mm/s), green low speed (3.3-6.3 mm/s), and black
inactive (<3.3 mm/s). (B) Percentage of time spent in light
region of the well by larvae (n=50, 45, 44 and 56 larvae for
mannitol, mannitol+SNP, glucose and glucose+SNP,
respectively). (C) Quantification of percentage time spent in
low and high speed locomotion in the light region by the same
animals as in B. (D) Quantification of percentage time spent in
low and high speed locomotion in the dark region by the same
animals as B andC. (E) Quantification of number of transitions
into the light/dark regions for same larvae as in B-D. Data are
mean±s.e.m. *P<0.05, **P<0.01 and ****P<0.0001.
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related freezing in glucose-exposed zebrafish would further
strengthen the link between diabetes and anxiety.
Zebrafish show acclimatisation to novel surroundings, which
could vary with developmental stage. Another future direction
would be to explore whether glucose and/or SNP treatment could
affect these acclimatization times (Kalueff et al., 2013).
In addition to being an effect of abnormal circuitry in theVd/Dm, the
observed impact of glucose exposure on the optic tectum may reflect
visual dysfunctions (in the visual cortex and superior colliculus), which
have been reported to occur before the onset of diabetes-associated
retinopathy in mammalian studies (Honda et al., 1998; Ozsoy et al.,
2012; Cui et al., 2014). Future studies with behaviour mapping to
precise neural substrates are needed to further investigate the impact of
glucose exposure on different brain circuitries.
Although human diabetes is a complex disorder and our zebrafish
model examines only the effect of hyperglycemia, our findings
broadly reproduce those in other cell-based and mammalian models
(Williams et al., 1996; Li et al., 2002). Diabetes is well known to
reduce vascular NO levels, and our work reproduces this. Although
zebrafish are not known to possess eNOS (Syeda et al., 2013), our
results strongly indicate vascular NO production. Previous studies
have linked hyperglycemia and pharmacologically induced diabetes
to reductions in cerebral blood flow (Dandona et al., 1978; Stevens
et al., 2000). A recent study demonstrated rescuing effects of the NO
donor SNP on hyperglycemia-induced neurovascular uncoupling
(Chhabria et al., 2018). Using the same protocol as described by
Chhabria et al. (2018) to induce hyperglycemia in larval zebrafish,
we have now described multiple effects of hyperglycemia on
cellular markers of the NVU, essential for regulation of CBF and on
zebrafish behaviour.
This is the first study to demonstrate that SNP reverses the
negative consequences of hyperglycemia on neurovascular
anatomy and behaviour. The ability of SNP to prevent all the
observed anatomical, molecular and behavioural effects of glucose
exposure is exciting as it may represent a possible treatment for
diabetes-associated neurovascular dysfunction. Future studies are
needed to assess whether these effects of glucose exposure and
SNP or other NO donors are seen in mammalian models or
humans. NO donors are already widely used clinically for angina
and heart failure, and are very cheap and off-patent. Therefore, if
mammalian preclinical studies support our findings, clinical
studies could rapidly be performed to examine the ability of NO
donors to ameliorate or prevent the consequences of diabetes on
neurological dysfunction.
MATERIALS AND METHODS
Transgenic zebrafish
All zebrafish studies were conducted in accordance with the Animals
(Scientific Procedures) Act, 1986, United Kingdom and covered by Home
Office Project Licence 70/8588 held by T.J.A.C. Reporting of experimental
outcomes were in compliance with ARRIVE (Animal Research: Reporting
In Vivo Experiments) guidelines (Kilkenny et al., 2010).
Maintenance of adult zebrafish was conducted according to previously
described husbandry standard protocols at 28°C with a 14:10 h light:dark
cycle (Lawrence, 2007).
The following zebrafish lines were used: Tg(kdrl:HRAS-mCherry)s916,
labelling EC membrane (Hogan et al., 2009); Tg(klf2a:GFP), expressing
GFP under control of the zebrafish klf2a promoter; Tg(sm22ab:nls-
mCherry)sh480, labelling mural cells expressing a smooth muscle actin-
binding protein; and Tg(nbt:GCaMP3), which allows quantification of
neuronal calcium levels (Bergmann et al., 2018).
Fig. 7. Effect of mannitol/glucose treatment with/
without sodium nitroprusside (SNP) on various
features of zebrafish locomotion. Quantification of
mean frequency of path eccentricities (A,D), mean point
distance to ellipsoid (MPDE; B,E) and mean point
distance to centre (MPDC; C,F) (n=50, 45, 44 and 56
larvae for mannitol, mannitol+SNP, glucose and
glucose+SNP, respectively) in (A-C) light and (D-F) dark
regions of the well. Data are mean±s.e.m. *P<0.05,
**P<0.01, ***P<0.001, ****P<0.0001.
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Glucose, mannitol and SNP treatment
Glucose, mannitol and SNP (Sigma) were prepared in E3 medium to final
concentrations of 20 mM (glucose and mannitol) or 0.1 mMSNP (Chhabria
et al., 2018). Zebrafish larvae for in vivo imaging or immunostaining were
incubated in E3medium containing glucose/mannitol from 4-9 dpf and SNP
from 8-9 dpf (Chhabria et al., 2018).
Assessment of NO reactivity in the cerebral vessels
Larvae exposed to glucose/mannitol with/without SNP as above were
incubated with 2.5 µM DAF-FM in DMSO (1%) at 9 dpf for 3 h at 28°C in
the incubator in the dark. Larvae were washed with glucose/mannitol
solution to remove excess DAF-FM, and then imaged on the lightsheet
fluorescent microscope (Zeiss Z1).
Glutamine synthetase, GFAP and TRPV4 immunohistochemistry
IHC was used to observe and quantify changes in TRPV4 (OST00071W;
Thermo Fisher Scientific) and the glial-specific markers GS (mab302;
Millipore) and GFAP (zrf-1; Zebrafish International Resource Center). The
protocol was adapted from Inoue and Wittbrodt (2011). Larvae for each
different treatment (mannitol or glucose, with or without co-treatment with
SNP)were fixed in 4%paraformaldehyde (PFA) overnight at 4°C followed by
a 5 min wash with 1× PBS before resuspending in 100% methanol (MeOH)
for storage at −20°C. Samples were rehydrated from MeOH with 3×10 min
washes with phosphate buffer saline+0.1% Tween 20 (PBST), with gentle
agitation on a rocker. Larvae were then suspended in 150 mM Tris-HCl
(pH 9) for 5 min, followed by heating at 70°C for 15 min. Larvae then
underwent 2×10 min washes with PBST, followed by 2× 5 min washes with
Fig. 8. Mathematical description of features
calculated from the larval trajectories.
(Top) Schematic diagram of the well showing
parameters calculated for various features.
(Bottom) Table describing the formulae of
calculated features for each coordinate of the
trajectories. The minimum enclosing ellipsoid
with centre (xe, ye) and major and minor axes of a
and b is defined as the unique closed ellipse of
smallest volumewhich enclose all points (xi, yi) of
a path. dci ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðxi  xaÞ2 þ ðyi  yaÞ2
q
is the
Euclidean distance of every point of the path to
centre of the well (xa,
ya). dei ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðxi  xeÞ2 þ ðyi  yeÞ2
q
is the distance
between the centre of minimum enclosing
ellipsoid (xe, ye) and ith point of the path. For each
feature, two distinctive numeric examples are
provided.
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distilled water (dH2O). Larvae were permeabilised using ice-cold acetone at
−20°C for 20 min, followed by 2×5 min washes with dH2O, then equilibrated
with 2×5 minwashes in PBST.Subsequently, larvaewere incubated in blocking
buffer (B-buffer: 10% sheep serum, 0.8% Triton X-100 and 1% bovine serum
albumin in PBST) for 3 h at 4°C. B-buffer was replaced with incubation buffer
(I-buffer: 1% sheep serum, 0.8% Triton X-100 and 1% bovine serum albumin
in PBST) containing the primary (1°) antibodies (Abs): 1:250 anti-GS (mouse
monoclonal; mab302; Millipore), 1:100 anti-GFAP (mouse monoclonal; zrf-1;
Zebrafish International ResourceCenter), 1:300 anti-TRPV4 (rabbit polyclonal;
OST00071W; Thermo Fisher Scientific) and 1:1000 DAPI followed by
incubation at 4°C for 3 days with gentle agitation on a rocker.
Residual 1° Abs were removed by 3× hourly washes in PBST [at room
temperature (RT)]. Larvae then underwent 2×10 min washes with PBS+1%
Triton X-100, followed by 2× hourly equilibration washes in PBS-TS
(PBS+1% Triton X-100+10% sheep serum).
Larvae were incubated in I-buffer containing secondary antibodies
(2° Abs): anti-rabbit, 488 nm (A11034, Invitrogen), anti-mouse, 647 nm
(A28181, Invitrogen) and anti-mouse, 568 nm (A11004, Invitrogen),
corresponding to respective 1° Abs, at 1:500 dilutions for 2.5 days, in the
dark on a rocker at 4°C.
Prior to imaging on the lightsheet microscope, larvae were washed three
times in PBS-TS (at RT), followed by two 1 h washes with PBST, each at
RT. Larvae were mounted in 1% low-melting-point agarose (LMP; Sigma)
and imaged for the glial patterning in the brain for different markers.
Lightsheet fluorescent imaging
Lightsheet fluorescent microscopy (LSFM) was performed on 9 dpf larvae
on a Zeiss Lightsheet Z.1 microscope. Larvae were minimally anaesthetised
(using 4.2% v/v tricaine methanesulfonate) and embedded in 1% agarose in
a glass capillary (inner diameter ∼1 mm) while imaging. We acquired 3D
z-stacks with 800×600 pixels (1 pixel=0.6 µm) in x-y direction and a depth
of 100 slices in z directions (slice thickness=1 µm).
For imaging spontaneous neuronal activity, we acquired time lapses of
single ‘z’ plane optic tectum with our previous acquisition settings and
frequency quantifications (Chhabria et al., 2018).
Image analysis: klf2a quantification
Acquired 3D image stacks were converted to 2D maximum-intensity
projections and the tectal vasculature was segmented out. Tectal vascular
length was extracted (Chhabria et al., 2018). The segmented vasculature was
used as a binary mask, followed by normalising the total intensity of the
green channel (klf2a:GFP) in the optic tectum to the tectal vascular length.
Image analysis: quantification of vascular mural cells
Acquired 3D image stacks were converted to 2D maximum-intensity
projections followed by segmenting the sm22absh480 nuclei (red channel)
using intensity-based thresholding similar to the method of RBC
segmentation described in Chhabria et al. (2018). Segmented cells in the
optic tectum were enumerated (in a fixed vascular volume) using custom-
written MATLAB scripts used for all treatment groups.
Behavioural analysis
Light/dark preference
Analysis of light/dark preference of the larval zebrafish was designed on a
similar principle to that of the adult zebrafish light/dark preference test
(Blaser and Penalosa, 2011). A 12-well platewasmodified by adhering three
cellophane films (blue, green and yellow) to half of each well to create a
‘dark’ side that allowed the camera to track larvae movement by infrared
(IR). Larvae from different treatment groups were placed on the light side of
the well filled with 5 ml E3 (without Methylene Blue).
The plate was placed inside a Viewpoint Zebrabox system (1% light
intensity) and the tracking protocol was built allocating dark and light regions
of each well prior to the start of imaging (to get x,y coordinates of dark/light
regions separately for analysis). Speed thresholds were set as high speed
>6.4 mm/s, low speed 3.3-6.3 mm/s and inactive <3.3 mm/s. Total
experimental duration was 1 h, inclusive of acclimatisation (recording started
immediately after adding larvae to an individual well) to capture the overall
behaviour. Analysis of parameters such as% time spent in the light, and% time
spent in high and low speed locomotionwere calculated in 1-min bins, and then
averaged across the hour for each animal or averaged for 15-min intervals
(Fig. S1). All the values of % time spent in low and high speed locomotion are
normalised to % time spent in light and dark to avoid confounds due to
differences in % time spent in light/dark for various treatment groups.
Automated locomotion analysis
Using previous rodent-based methods developed for the Morris water maze
(Wolfer and Lipp, 2000; Graziano et al., 2003; Gehring et al., 2015; Illouz
et al., 2016; Vouros et al., 2018), we quantified four different features from the
swimming trajectories of zebrafish. Coordinates of the swimming trajectories
were extracted from the Viewpoint Zebrabox system and were segmented into
smaller paths delimited by light/dark, followed by quantification of path
features listed in Fig. 8. Small path segments, with lengths lower than 1st
percentile of segments, generated as an artefact of light/dark transitions, were
removed from further analysis. The path features eccentricity (ε) and MPDE
quantify the spatial elongation of the locomotion trajectories and are used as
measures of exploration in the field, while MPDC of the well represents
thigmotaxis (preference of edge versus centre of well). Additionally, we
quantified the number of transitions between light and dark areas (Fig. 8).
Experimental design and statistical analysis
Experiments were designed using the National Centre for Replacement,
Refinement, and Reduction of Animals in Research (NC3Rs) experimental
design analysis (EDA) tool. GraphPad Prism (La Jolla) was used for statistical
comparisons. Before performing statistical analysis, data were tested for
normality using the Shapiro–Wilk test. All intergroup comparisons were
performed using two-way ANOVA with post-hoc multiple-comparison tests
(Sidak’s test), where appropriate. P-values <0.05 were considered to be
statistically significant. Data are shown as mean±standard error of mean
(s.e.m.) unless specified. Imaging was performed unblinded to treatment
allocation; data analysis was automated and thus not subject to operator bias.
Randomisation of larvae to treatment group was not performed. All the data
and MATLAB codes are available on request.
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